Asian Spectator

.
Business Advice

.

Octa’s compelling Ramadan 2023—Memories which become templates for the future

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 27 March 2024 - It is time to recall all the Ramadan initiatives the international broker Octa has launched and curated throughout the last year. C...

Toyota and FAW Restructure their Joint Company's Management Systems with the Aim of Sustainable Growth in China

Toyota City, Japan, Apr 27, 2020 - (JCN Newswire) - China FAW Group Co., Ltd. (FAW) and Toyota Motor Corporation (Toyota) will restructure their management systems with the aim of achieving...

Hitachi Acquired Additional Shares to Hold Majority of Shares of Yungtay, Elevator Company Based in Taiwan

TAIPEI, TAIWAN, Oct 15, 2020 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) today announced that it acquired 9.99% (41,080,000 shares) of all the issued shares in Yungtay Engineering Co., Ltd...

Heidrick Struggles Adds New Consultant in the Middle East

HONG KONG, Oct. 18, 2022 /PRNewswire-AsiaNet/ -- Heidrick & Struggles( https://c212.net/c/link/?t=0&l=en&o=3680226-1&h=1144637666&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3...

Chiba Pref. Gov't Soliciting Tourists to Pick Strawberries, In...

CHIBA, Japan, Feb. 18, 2020 /Kyodo JBN-AsiaNet/ -- As part of its spring tourism promotion campaign, the Chiba Prefectural Government is soliciting tourists to visit local strawberry farms t...

Under the theme Flickering Shores, Sea Imaginaries , Sea Art Festival in Busan runs until November 19

BUSAN, SOUTH KOREA - Media OutReach - 20 October 2023 - Organized by the Busan Biennale Organizing Committee, Sea Art Festival is one of the most seminal and accessible outdoor art exhibiti...

Joy Forum19 to boost Saudi entertainment sector

RIYADH, Saudi Arabia, Oct. 12, 2019 /PRNewswire-AsiaNet/-- The Joy Entertainment Industry Forum (Joy Forum19), takes place October 13-14 at the Ritz-Carlton in Riyadh, and brings together en...

Hong Kong Investment Promotion Chief visits Europe to promote Hong Kong's unique business advantages

Mr Stephen PhillipsHONG KONG, Jun 24, 2019 - (ACN Newswire) - The Director-General of Investment Promotion of the Hong Kong Special Administrative Region, Mr Stephen Phillips, today (June 2...

tenso, inc. Starts Full Indonesian-language Support for Indust...

TOKYO, Feb. 17, 2020 /Kyodo JBN-AsiaNet/-- -Most Popular Toy Figures and Branded Watches Now Available in Indonesian-tenso, inc. (hereinafter "tenso"), a subsidiary of BEENOS Inc. and operat...

Jacobson Pharma Launches First Influenza/RSV Home Diagnostic Kit in Hong Kong and Macau

Jacobson Pharma Launches First Influenza/RSV Home Diagnostic Kit in Hong Kong and Macau

HONG KONG, Feb 5, 2020 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of generic drugs and branded healthcare products, announced the launch of its first home diagnostic product for influenza/RSV under the brand name of "Dr. Freeman Flu/RSV Combo" (the "Product") in Hong Kong and Macau since January 2020. The product is available in different over-the-counter channels including major healthcare chain stores and drug stores.

Jacobson Pharma Launches First Influenza/RSV Home Diagnostic Kit in Hong Kong and Macau

Jacobson launches Dr. Freeman Flu/RSV Combo as its first influenza/RSV home diagnostic kit in the markets of Hong Kong and Macau. It is designed for qualitative determination of specific types of Influenza A and B virus and respiratory syncytial virus ("RSV") with test results available in 8 minutes.

Dr. Freeman Flu/RSV Combo is a handy one-step home diagnostic test designed for qualitative determination of specific types of Influenza A and B virus and respiratory syncytial virus ("RSV") with test results available in 8 minutes. The Product marks the first among others of its home diagnostic portfolio to be launched under the branded healthcare business platform of the Group. The Group is contemplating a potential strategic spin-off of its branded healthcare business which comprises proprietary medicines, proprietary Chinese medicines and branded health and wellness products such as health supplements, personal care products and diagnostic kits. In scientific terms, Dr. Freeman Flu/RSV Combo uses monoclonal antibodies specific to the corresponding antigens of influenza and RSV for determination of the specific types of influenza and RSV infected, apart from the indication of the presence of influenza.

Mr Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, commented, "We are very pleased for bringing in this useful home diagnostic product for influenza /RSV to the markets in Hong Kong and Macau. As a handy, speedy and specific self-diagnostic tool for the communicable disease, we believe the Product can highly benefit the public by helping influenza/RSV infected patients to seek prompt and effective medical treatment at the onset of the illnesses, especially during the peak flu seasons.

Bearing with the commitment to fulfilling unmet healthcare needs of consumers, we will continue to enhance our portfolio with high quality, innovative and well-trusted products in the expansion of our branded healthcare business as a strategic growth platform. Our ongoing efforts are set to strengthen our long-term strategic position and thereby enhancing the shareholders' values.".

About Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is a leading generic drug company in Hong Kong. The Group's proprietary brand portfolio, notably being Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex Scar Gel, Flying Eagle Wood Lok Medicated Oil, Tong Tai Chung Woodlok Oil, Doan's Ointment, Saplingtan, Shiling Oil and Col-gan Tablet have been widely recognised by the market. The Group aims at the continued strategic enrichment of both of its generic drug and branded healthcare portfolios through the addition of high value-added products. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan, Singapore and Cambodia forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com

For media enquiries, please contact:Strategic Financial Relations LimitedVicky Lee Tel: (852) 2864 4834 Email: vicky.lee@sprg.com.hkStephanie Liu Tel: (852) 2864 4852 Email: stephanie.liu@sprg.com.hkRachel Ko Tel: (852) 2864 4806 Email: rachel.ko@sprg.com.hkFax: (852) 2527 1196

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Disparitas pemidanaan: mengapa pelaku kekerasan seksual bisa mendapat hukuman berbeda-beda untuk kasus serupa?

Ilustrasi korban kekerasan seksual.Tinnakorn jorruang/ShutterstockPraktik hukum di Indonesia masih menunjukkan adanya disparitas pemidanaan, yakni ketika ada dua orang atau lebih melakukan tindak pida...

8 aspek penting untuk memastikan keberlanjutan industri nikel dari hulu ke hilir

Isu mengenai hilirisasi nikel Indonesia tengah panas beberapa tahun ke belakang. Ambisi Presiden Joko Widodo untuk menjadikan Indonesia sentra produksi baterai kendaraan listrik (EV) dunia membuat akt...

Gangguan dismorfik tubuh: apa yang perlu kita ketahui tentang kondisi kesehatan mental ini

Selebritas Megan Fox dalam sebuah wawancara dengan Sports Illustrated mengungkapkan bahwa dia memiliki dismorfik tubuh (body dysmorphia). Fox mengatakan: “Saya tidak pernah melihat diri saya sep...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion